Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Merck to develop vaccine manufacturing processes with International Vaccine Institute Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
Production & Manufacturing > Manufacturing > News
Intensity Therapeutics raises $10m to fund clinical supplies manufacturing and phase I/II trials of INT230-6 Intensity Therapeutics, a privately held biotechnology company developing proprietary cancer immunotherapy products, has secured $10 million in new capital from a Series A preferred stock financing.
Production & Manufacturing > Manufacturing > News Sanofi, Boehringer Ingelheim to swap animal, consumer health assets By PBR Staff Writer
Sanofi and Boehringer Ingelheim have signed contracts to exchange their respective animal health and consumer healthcare businesses.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Sanofi, Boehringer Ingelheim to swap animal, consumer health assets
By PBR Staff Writer
Sanofi and Boehringer Ingelheim have signed contracts to exchange their respective animal health and consumer healthcare businesses.
Production & Manufacturing > Manufacturing > News
Kite Pharma opens T-Cell therapy manufacturing facility in California
Kite Pharma has opened its new commercial manufacturing facility in El Segundo, California.
Production & Manufacturing > Manufacturing > News
FDA accepts Emergent's sLBA for large-scale manufacturing of BioThrax in Building 55
The US Food and Drug Administration (FDA) has accepted for review Emergent BioSolutions' supplemental Biologics License Application (sBLA) seeking approval of the manufacture of BioThrax (Anthrax Vaccine Adsorbed) in Building 55, the company’s large-scale manufacturing facility.
Production & Manufacturing > Manufacturing > News
Valeant Pharmaceuticals unveils significant investments in Canadian operations
Valeant Pharmaceuticals International's wholly-owned subsidiary Valeant Canada is expanding its Canadian manufacturing and export capacity with investments totaling $27.5m in its Steinbach, Manitoba and Laval, Quebec manufacturing facilities.
Production & Manufacturing > Manufacturing > News
Pfizer breaks ground on new $200m biologics manufacturing plant in Massachusetts
By PBR Staff Writer
US biopharmaceutical firm Pfizer has broke ground on a new $200m biologics clinical manufacturing facility in Andover, Massachusetts.
Production & Manufacturing > Manufacturing > News
Genticel completes two milestones in preparation for phase 3 program of GTL001
Genticel has confirmed the ability to use widely available genotyping HPV tests in the planned phase 3 program of GTL001, the company's most advanced therapeutic vaccine candidate against HPV 16/18 infections.
Production & Manufacturing > Manufacturing > News
Dr. Reddy's to buy eight US drugs from Teva and Allergan for $350m
By PBR Staff Writer
Dr. Reddy's Laboratories has agreed to acquire a portfolio of eight abbreviated new drug applications (ANDA) in the US from Teva Pharmaceutical Industries and an affiliate of Allergan for $350m.
Production & Manufacturing > Manufacturing > News
Frontida Acquires Sun Pharmaceuticals' Philadlelphia and Aurora facilities
Frontage Laboratories' affiliate company, Frontida BioPharm has acquired certain assets from a wholly owned US subsidiary of Sun Pharma.
Production & Manufacturing > Manufacturing > News
Fujifilm Diosynth to collaborate with Merck on new microbial biologics facility
FUJIFILM Diosynth Biotechnologies is in the process of establishing a long-term collaboration with MSD, a global biopharmaceutical company known as Merck in the U.S. and Canada, to invest in and operate a large-scale microbial-biologics facility for supply of active pharmaceutical ingredient (API) to its customers.
Production & Manufacturing > Manufacturing > News
Shire completes $32bn acquisition of Baxalta
By PBR Staff Writer
Shire has completed its $32bn acquisition of of Baxalta, creating a global biotechnology company specializing in rare diseases and conditions.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests